Functions of Translocated Bacterial Glycosyltransferases

易位细菌糖基转移酶的功能

基本信息

  • 批准号:
    9222103
  • 负责人:
  • 金额:
    $ 18.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-12-07 至 2018-11-30
  • 项目状态:
    已结题

项目摘要

Project Summary. Infectious diarrhea constitutes a major endemic health threat as an increasingly frequent and deadly source of food- and water-borne illness. Enterohemorrhagic Escherichia coli (EHEC) are especially significant bacterial pathogens because their toxins can cause a type of renal failure (hemolytic uremic syndrome) for which therapy is limited. The molecular mechanisms by which EHEC and the closely related enteropathogenic E. coli (EPEC), as well as Salmonella enterica serovar Typhimurium, a common cause of human gastroenteritis, inhibit host innate immune responses to promote bacterial colonization are under intense investigation. Understanding these host-pathogen dynamics in molecular detail may enhance the development of pharmacological approaches to prevent and treat infections. Through studies of the mechanism of the NleB virulence protein expressed by E. coli and by a related pathogen of mice, Citrobacter rodentium, it was determined that NleB functions as a glycosyltransferase enzyme that covalently modifies host proteins with N-acetylglucosamine (GlcNAc) to subvert their normal functions. NleB disrupts tumor necrosis factor receptor (TNFR)-associated factor 2 (TRAF2) signaling, leading to inhibition of the pro-inflammatory NF-κB pathway. The glycolysis enzyme GAPDH functions as a co- activator of TRAF2 activity. The modification of GAPDH with GlcNAc by NleB prevents GAPDH from binding to and activating TRAF2, leading to a reduced NF-κB response to infection and thus enhanced bacterial survival. It was also discovered that some NleB orthologs modify the arginine residues of host proteins, rather than the expected modification of their serine/threonine residues. S. Typhimurium strains also encode from 1-3 NleB orthologs named SseK/1/2/3, although their enzymatic activities and relative contributions to virulence are less clear. The proposed project is designed to elucidate the molecular mechanisms of NleB/SseK glycosyltransferase activities, with the ultimate goal of using these data to inform future strategies to prevent and treat infectious diarrhea. The specific aims are: 1) Elucidate the NleB/SseK GlcNAcylation mechanisms and their targeting of host proteins. 2) Identify GAPDH GlcNAcylation sites and characterize their role in GAPDH activity and NF-κB pathway activation. This multidisciplinary approach provides an opportunity to probe not only the enzymology of these virulence factors, but also to effect the future development of small molecules with anti-virulence properties.
项目摘要。 感染性腹泻是一种主要的地方性健康威胁,因为它是一种日益频繁和致命的 通过食物和水传播的疾病。肠出血性大肠杆菌(EHEC)是一种特别重要的细菌 病原体,因为它们的毒素可以导致一种类型的肾功能衰竭(溶血性尿毒症综合征) 治疗是有限的。肠出血性大肠杆菌与致病性肠出血性大肠杆菌分子机制的研究进展 (EPEC),以及人类胃肠炎的常见原因--鼠伤寒沙门氏菌, 抑制宿主先天免疫反应以促进细菌定植的研究正在紧张进行中。 在分子细节上了解这些寄主-病原体的动力学可能会促进 预防和治疗感染的药理学方法。 通过对大肠杆菌和相关菌株表达的NleB毒力蛋白机制的研究 小鼠的病原体轮状柠檬酸杆菌,已确定NleB具有糖基转移酶的功能 与N-乙酰氨基葡萄糖(GlcNAc)共价修饰宿主蛋白以颠覆其正常状态的酶 功能。NleB干扰肿瘤坏死因子受体(TNFR)相关因子2(TRAF2)信号,导致 抑制促炎因子-κB途径。糖酵解酶GAPDH的功能是辅酶-2。 TRAF2活性激活剂。NleB用GlcNAc修饰GAPDH可阻止GAPDH与 激活TRAF2,导致对感染的NF-κB反应减少,从而提高细菌存活率。 还发现一些NleB同源基因可以修饰宿主蛋白的精氨酸残基,而不是 预期对其丝氨酸/苏氨酸残基进行修饰。鼠伤寒沙门氏菌也编码1-3个NleB 同源基因命名为SseK/1/2/3,尽管它们的酶活性和对毒力的相对贡献较小 安全。 该项目旨在阐明NleB/SseK的分子机制 糖基转移酶活动,最终目的是利用这些数据为未来的预防战略提供信息 治疗感染性腹泻。具体目的是:1)阐明NleB/SseK GlcN酰化机制 以及它们对宿主蛋白的靶向。2)确定GAPDHGlcN酰化位点并表征它们在 GAPDH活性和NF-κB通路的激活。这种多学科的方法提供了一个机会 不仅探讨了这些毒力因子的酶学性质,而且还影响了小球虫的未来发展。 具有抗病毒特性的分子。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Philip Ross Hardwidge其他文献

Philip Ross Hardwidge的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Philip Ross Hardwidge', 18)}}的其他基金

T3SS Effector Regulation of Bacterial Metabolism
T3SS 细菌代谢的效应器调节
  • 批准号:
    10425770
  • 财政年份:
    2022
  • 资助金额:
    $ 18.75万
  • 项目类别:
Molecular and Cellular Biology Core
分子和细胞生物学核心
  • 批准号:
    10642676
  • 财政年份:
    2020
  • 资助金额:
    $ 18.75万
  • 项目类别:
Molecular and Cellular Biology Core
分子和细胞生物学核心
  • 批准号:
    10397674
  • 财政年份:
    2020
  • 资助金额:
    $ 18.75万
  • 项目类别:
An enterotoxigenic E. coli protein that antagonizes the NF-kappaB pathway
一种拮抗 NF-kappaB 通路的产肠毒素大肠杆菌蛋白
  • 批准号:
    8891351
  • 财政年份:
    2014
  • 资助金额:
    $ 18.75万
  • 项目类别:
Bacterial effectors targeting the IKK/NF-kB pathway
针对 IKK/NF-kB 通路的细菌效应子
  • 批准号:
    8791592
  • 财政年份:
    2013
  • 资助金额:
    $ 18.75万
  • 项目类别:
Bacterial effectors targeting the IKK/NF-kB pathway
针对 IKK/NF-kB 通路的细菌效应子
  • 批准号:
    9188797
  • 财政年份:
    2013
  • 资助金额:
    $ 18.75万
  • 项目类别:
Bacterial effectors targeting the IKK/NF-kB pathway
针对 IKK/NF-kB 通路的细菌效应子
  • 批准号:
    8495491
  • 财政年份:
    2013
  • 资助金额:
    $ 18.75万
  • 项目类别:
Reverse vaccinology of enterotoxigenic E. coli
产肠毒素大肠杆菌的反向疫苗学
  • 批准号:
    8518225
  • 财政年份:
    2012
  • 资助金额:
    $ 18.75万
  • 项目类别:
Bacterial effectors targeting the IKK/NF-kB pathway
针对 IKK/NF-kB 通路的细菌效应子
  • 批准号:
    8589734
  • 财政年份:
    2012
  • 资助金额:
    $ 18.75万
  • 项目类别:
Reverse vaccinology of enterotoxigenic E. coli
产肠毒素大肠杆菌的反向疫苗学
  • 批准号:
    8589931
  • 财政年份:
    2012
  • 资助金额:
    $ 18.75万
  • 项目类别:

相似海外基金

CAREER: Elucidating the Synergistic Nanoscale and Carbohydrate Interactions of Glyconanomaterials with Bacterial Proteins, Toxins, and Cells
职业:阐明聚糖纳米​​材料与细菌蛋白质、毒素和细胞的协同纳米级和碳水化合物相互作用
  • 批准号:
    2142579
  • 财政年份:
    2022
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Standard Grant
Development of machine learning methods for automated design of new biological functions in bacterial proteins.
开发机器学习方法,用于自动设计细菌蛋白质的新生物功能。
  • 批准号:
    2600923
  • 财政年份:
    2021
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Studentship
Heme transport in bacterial proteins using mass spectrometry and magnetic circular dichroism spectro
使用质谱和磁圆二色光谱分析细菌蛋白质中的血红素转运
  • 批准号:
    526817-2018
  • 财政年份:
    2018
  • 资助金额:
    $ 18.75万
  • 项目类别:
    University Undergraduate Student Research Awards
Bacterial proteins as formulation ingredients.
细菌蛋白作为配方成分。
  • 批准号:
    BB/N022254/1
  • 财政年份:
    2016
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Research Grant
Production of difficult to express essential bacterial proteins
生产难以表达的必需细菌蛋白
  • 批准号:
    BB/P004237/1
  • 财政年份:
    2016
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Research Grant
Cell surface display of bacterial proteins
细菌蛋白质的细胞表面展示
  • 批准号:
    BB/N000951/1
  • 财政年份:
    2016
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Research Grant
Phosphorylation and acetylation of secreted bacterial proteins: a new regulatory
分泌细菌蛋白的磷酸化和乙酰化:新的调控
  • 批准号:
    8778792
  • 财政年份:
    2014
  • 资助金额:
    $ 18.75万
  • 项目类别:
The protein O-glycosylation pathway of Neisseria: a model system for O-glycosylation of bacterial proteins with potential use in biotechnology
奈瑟氏球菌的蛋白质 O-糖基化途径:细菌蛋白质 O-糖基化的模型系统,具有生物技术的潜在用途
  • 批准号:
    DP130103141
  • 财政年份:
    2013
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Discovery Projects
Preclinical study to elucidate molecular mechanism of matrix anchoring using bacterial proteins
利用细菌蛋白阐明基质锚定分子机制的临床前研究
  • 批准号:
    23590516
  • 财政年份:
    2011
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterisation of the bacterial proteins YjeE, YeaZ and YgjD and evaluation as a potential novel antimicrobial target
细菌蛋白 YjeE、YeaZ 和 YgjD 的表征以及作为潜在新型抗菌靶点的评估
  • 批准号:
    G1100376/1
  • 财政年份:
    2011
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了